Reaction

Toxic Anterior Segment Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,075 reports · 27 co-occurring drugs

As of the last recalculation, Toxic Anterior Segment Syndrome appears in 1,075 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is MOXIFLOXACIN HYDROCHLORIDE (PRR 196.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Moxifloxacin Hydrochloride173196.7198.4
Prednisolone Acetate62123.1123.8
Moxifloxacin5985.786.1
Lidicaine16878.678.9
Burn Relief16878.678.9
Lidocaine Hydrochloride And Epinephrine16878.578.8
Lidocaine, Menthol16877.577.8
Lidocaine Hydrochloride And Epinephrine Bitartrate17877.277.5
Lidocaine Hydrochloride19576.376.5
Lidocaine 4%17574.174.3
Lidocaine17569.269.4
Faricimab2151.251.3
Timolol Maleate2345.946.0
Adrenalinum8844.644.7
Aflibercept5535.936.0
Epinephrine9731.431.5
Cefuroxime1729.229.3
Dorzolamide Hydrochloride And Timolol Maleate922.222.2
Vancomycin6121.621.6
Vancomycin Hydrochloride6219.319.3
Brimonidine Tartrate1415.415.4
Tobramycin Solution813.013.0
Timolol812.912.9
Tobramycin Sulfate812.612.6
Ranibizumab1611.811.8
Bevacizumab609.99.9
Tobramycin108.18.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.